Regeneron Pharmaceuticals Inc (REGN)
Statistics
Key valuation multiples, financial performance ratios, profitability metrics, and per share data consolidated into a single structured view. Each metric is benchmarked against both industry and sector averages — providing immediate context on whether the company is trading at a premium or discount relative to its direct peers and the broader market segment.
Valuation & Market Metrics
Market Capitalization
$94.76B
EV to revenue ratio (TTM)
5.24
EV to ebitda
14.18
Financial Performance
Revenue (TTM)
$16.90B
Gross profit (TTM)
$7.90B
EBITDA
$5.65B
Profitability
Operating margin (TTM)
40.50%
Profit margin
28.50%
Return on assets (TTM)
7.59%
Return on equity (TTM)
14.90%
Per Share Metrics
Revenue per share (TTM)
$164.24
EPS
$45.24
Diluted EPS (TTM)
$45.24
Book value
$333.93
Dividend per share
$3.70
Dividend yield
0.40%
Valuation Multiples
P/E ratio
20.25
Trailing P/E
20.25
Forward P/E
13.51
PEG ratio
1.12
Price to sales ratio (TTM)
5.61
Price to book ratio (TTM)
2.84
Growth
Quarterly earnings growth (YoY)
36.30%
Quarterly revenue growth (YoY)
35.50%
Analyst Sentiment
Strong buy
4
Buy
15
Hold
8
Sell
0
Strong sell
1
Risk & Volatility
Beta
0.10